Leukocyte telomere shortening in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality.
作者信息
Kim Donghee, Danpanichkul Pojsakorn, Wijarnpreecha Karn, Cholankeril George, Ahmed Aijaz
机构信息
Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA.
Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
出版信息
Clin Mol Hepatol. 2024 Oct;30(4):982-986. doi: 10.3350/cmh.2024.0691. Epub 2024 Aug 27.
Abstract
摘要
相似文献
1
Leukocyte telomere shortening in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality.代谢功能障碍相关脂肪性肝病中的白细胞端粒缩短与全因/特定病因死亡率
Clin Mol Hepatol. 2024 Oct;30(4):982-986. doi: 10.3350/cmh.2024.0691. Epub 2024 Aug 27.
2
Weight-adjusted waist index is positively and linearly associated with all-cause and cardiovascular mortality in metabolic dysfunction-associated steatotic liver disease: findings from NHANES 1999-2018.体重调整腰围指数与代谢功能障碍相关脂肪性肝病患者的全因和心血管死亡率呈正线性相关：来自 NHANES 1999-2018 的研究结果。
Front Endocrinol (Lausanne). 2024 Sep 30;15:1457869. doi: 10.3389/fendo.2024.1457869. eCollection 2024.
3
Impact of steatotic liver disease subtypes, sarcopenia, and fibrosis on all-cause and cause-specific mortality: a 15.7-year cohort study.脂肪性肝病亚型、肌肉减少症和肝纤维化对全因死亡率和特定病因死亡率的影响：一项15.7年的队列研究。
BMC Gastroenterol. 2025 Feb 11;25(1):75. doi: 10.1186/s12876-025-03661-0.
4
Estimated pulse wave velocity in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality.代谢相关脂肪性肝病患者脉搏波速度与全因/死因特异性死亡率的关系。
J Gastroenterol Hepatol. 2024 Sep;39(9):1950-1956. doi: 10.1111/jgh.16608. Epub 2024 May 13.
5
NPR is an independent risk factor for predicting all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease: evidence from NHANES 2007-2020.中性粒细胞与淋巴细胞比值（NPR）是预测代谢功能障碍相关脂肪性肝病患者全因死亡率的独立危险因素：来自2007 - 2020年美国国家健康与营养检查调查（NHANES）的证据。
Popul Health Metr. 2025 Apr 25;23(1):15. doi: 10.1186/s12963-025-00378-w.
6
Association between periodontitis and mortality in participants with metabolic dysfunction-associated steatotic liver disease: results from NHANES.代谢功能障碍相关脂肪性肝病参与者中牙周炎与死亡率的关联：美国国家健康与营养检查调查结果
BMC Oral Health. 2025 Apr 13;25(1):567. doi: 10.1186/s12903-025-05959-7.
7
Association of plain water intake with risk of all-cause and cause-specific mortality in individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease.非酒精性脂肪性肝病或代谢功能障碍相关脂肪性肝病患者的纯水摄入量与全因死亡率及特定病因死亡率的关联
Front Nutr. 2024 Oct 30;11:1478194. doi: 10.3389/fnut.2024.1478194. eCollection 2024.
8
Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease.代谢相关脂肪性肝病和非酒精性脂肪性肝病的临床特征和病死率相似。
J Hepatol. 2024 May;80(5):694-701. doi: 10.1016/j.jhep.2024.01.014. Epub 2024 Jan 27.
9
Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden.瑞典13099例代谢功能障碍相关脂肪性肝病患者的病因特异性死亡率。
J Hepatol. 2025 Mar 24. doi: 10.1016/j.jhep.2025.03.001.
10
Metabolic Dysfunction-Associated Steatotic Liver Disease and All-Cause and Cause-Specific Mortality.代谢功能障碍相关脂肪性肝病与全因死亡率和特定病因死亡率
Diabetes Metab J. 2025 Jan;49(1):80-91. doi: 10.4093/dmj.2024.0042. Epub 2024 Aug 28.
引用本文的文献
1
Increased MASH-associated liver cancer in younger demographics.在较年轻人群中，与MASH相关的肝癌有所增加。
Hepatol Commun. 2025 Jan 7;9(1). doi: 10.1097/HC9.0000000000000629. eCollection 2025 Jan 1.
本文引用的文献
1
Epidemiology of metabolic dysfunction-associated steatotic liver disease.代谢功能障碍相关脂肪性肝病的流行病学
Clin Mol Hepatol. 2025 Feb;31(Suppl):S32-S50. doi: 10.3350/cmh.2024.0431. Epub 2024 Aug 19.
2
Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity.代谢功能障碍相关脂肪性肝病的批判性评价：两面性现代性的启示。
Clin Mol Hepatol. 2023 Oct;29(4):831-843. doi: 10.3350/cmh.2023.0277. Epub 2023 Aug 25.
3
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.多学会专家组关于新的脂肪肝疾病命名的德尔菲共识声明。
J Hepatol. 2023 Dec;79(6):1542-1556. doi: 10.1016/j.jhep.2023.06.003. Epub 2023 Jun 24.
4
Familial Clonal Hematopoiesis in a Long Telomere Syndrome.长端粒综合征中的家族性克隆性造血
N Engl J Med. 2023 Jun 29;388(26):2422-2433. doi: 10.1056/NEJMoa2300503. Epub 2023 May 4.
5
The association between sleep quality and telomere length: A systematic literature review.睡眠质量与端粒长度之间的关联：一项系统的文献综述。
Brain Behav Immun Health. 2023 Jan 9;28:100577. doi: 10.1016/j.bbih.2022.100577. eCollection 2023 Mar.
6
Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者死亡的原因和风险概况。
Clin Mol Hepatol. 2023 Feb;29(Suppl):S43-S57. doi: 10.3350/cmh.2022.0351. Epub 2022 Nov 22.
7
Association of Telomere Length With Risk of Disease and Mortality.端粒长度与疾病风险和死亡率的关联。
JAMA Intern Med. 2022 Mar 1;182(3):291-300. doi: 10.1001/jamainternmed.2021.7804.
8
Recent Epidemiology of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病的最新流行病学。
Gut Liver. 2021 Mar 15;15(2):206-216. doi: 10.5009/gnl20127.
9
Long telomeres and cancer risk: the price of cellular immortality.端粒较长与癌症风险：细胞不朽的代价。
J Clin Invest. 2019 Aug 5;129(9):3474-3481. doi: 10.1172/JCI120851.
10
Physical Activity and Nutrition: Two Promising Strategies for Telomere Maintenance?体力活动与营养：端粒维持的两种有前途策略？
Nutrients. 2018 Dec 7;10(12):1942. doi: 10.3390/nu10121942.
Zotero 插件